Procter & Gamble (PG) director reports 215-share RSU award, total holding 2,409.2016
Rhea-AI Filing Summary
Procter & Gamble Co. reported an equity award to a director under its stock compensation plan. On 12/09/2025, a director of PROCTER & GAMBLE Co (PG) acquired 215 shares of common stock in the form of Restricted Stock Units at a price of $0, reflecting a non-cash grant under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
After this transaction, the director beneficially owned a total of 2,409.2016 shares, including dividend equivalents that were also granted as Restricted Stock Units. The filing is made as a Form 4 by one reporting person in the capacity of director, documenting routine equity-based compensation rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 215 | $0.00 | -- |
Footnotes (1)
- Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Total includes grant of dividend equivalents in the form of Restricted Stock Units.
FAQ
What insider transaction did Procter & Gamble (PG) report in this Form 4?
The filing shows that a director of Procter & Gamble acquired 215 shares of common stock in the form of Restricted Stock Units on 12/09/2025 as an equity award.
Was the Procter & Gamble (PG) director’s Form 4 transaction a purchase or an equity grant?
The transaction was an equity grant, not an open-market purchase. The director received 215 Restricted Stock Units at a stated price of $0 under the company’s 2025 Stock and Incentive Compensation Plan.
What plan governed the Restricted Stock Unit grant reported by Procter & Gamble (PG)?
The 215 Restricted Stock Units were awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan, as noted in the explanation of responses.
Is this Procter & Gamble (PG) Form 4 filed by one or multiple reporting persons?
The document indicates that it is a Form filed by one reporting person, who serves as a director of Procter & Gamble Co.
Does the Procter & Gamble (PG) Form 4 involve any derivative securities transactions?
Table II for derivative securities is present but shows no entries, indicating no reportable derivative security transactions in this filing.